A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar, +3

New England Journal of Medicine

Prevalence of Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar, +6

New England Journal of Medicine

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau, +9

New England Journal of Medicine

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

S. Vincent Rajkumar, Robert A. Kyle, Terry M. Therneau, +7

Blood

Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001

Joseph A. Murray, Carol Van Dyke, Matthew F. Plevak, +3

Clinical Gastroenterology and Hepatology

Food IntoleranceNorth American CommunityClinical EpidemiologyGastroenterologyPathology +6

Long-term follow-up of IgM monoclonal gammopathy of undetermined significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar, +5

Blood

Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.

S. Vincent Rajkumar, Ruben A. Mesa, Rafaël Fonseca, +10

PubMed

Primary (AL) Hepatic Amyloidosis

Miguel A. Park, Paul S. Mueller, Robert A. Kyle, +3

Medicine

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

Angela Dispenzieri, Robert A. Kyle, Martha Q. Lacy, +20

Blood

Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays

Jerry A. Katzmann, Angela Dispenzieri, Robert A. Kyle, +7

Mayo Clinic Proceedings

UrologyMedicineBioanalysisDiagnosisPathology +7